KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Earnings Reports 8-K Filing 2023 - Financial Results Announcement Kiniksa Pharmaceuticals announced preliminary year-end 2022 financial results, with $190.4 million in cash and $122.5 million in net revenue for the full year.Get access to all SEC 8-K filings of the KINIKSA PHARMACEUTICALS INTERNATIONAL PLC